Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2022 | Genome characterization of T-ALL patients

Petri Pölönen • 9 Jun 2022
EHA 2022
Acute Lymphoblastic Leukemia Leukemia Rare Diseases

Petri Pölönen, PhD, St. Jude’s Research Hospital, Memphis, TN, discusses the results of a study which used whole genome sequencing (WGS), whole exome sequencing (WES), and transcriptome sequencing to characterize the genome of pediatric patients with T-cell acute lymphoblastic leukemia (T-ALL). Dr Pölönen highlights novel T-ALL driver genes and genomic alterations that were identified. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

More from Petri Pölönen

Using WGS and transcriptome sequencing to improve prognostic classification in T-ALL
1:33
Using WGS and transcriptome sequencing to improve prognostic classification in T-ALL
Petri Pölönen • 9 Jun 2022

Related Videos

LENAZART: lenalidomide, oral azacitidine, & radiotherapy in newly diagnosed & relapsed plasmacytoma
3:31
LENAZART: lenalidomide, oral azacitidine, & radiotherapy in newly diagnosed & relapsed plasmacytoma
Urvi Shah • 25 Sep 2026
Unmet needs in CLL genomics: heterogeneity and clinical impact
1:11
Unmet needs in CLL genomics: heterogeneity and clinical impact
Elias Campo • 16 Oct 2026
Insights into key topics most likely to impact day-to-day CLL management
1:40
Insights into key topics most likely to impact day-to-day CLL management
Alessandra Ferrajoli • 16 Oct 2026
Translating current CLL evidence into national guidelines: which gaps remain?
3:33
Translating current CLL evidence into national guidelines: which gaps remain?
Mary Ann Anderson • 16 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals